From the Texas Government Insider, published Friday, June 22, 2012:
An economic impact of more than $1.3 billion in Texas is expected from the announcement that the Texas A&M University System has been awarded a $285.6 million contract to develop a center whose goal will be to enhance the United States’ ability to counter biological and pandemic threats. The Center for Innovation in Advanced Development and Manufacturing will represent one of the largest research grants to come to Texas since NASA, said TAMU System Chancellor John Sharp.
Of the total contract, $176 million will come from the federal government, with the remainder from academic and commercial partners and the state. The facility is expected to be operational by December 2015.
Sharp said the center will allow the United States to counter biological and pandemic threats with vaccines manufactured in this country. He said <!– –>the need for this capability was identified following a comprehensive review of federal public health emergency medical countermeasures called for by President Barack Obama in his 2010 State of the Union address. The Department of Health and Human Services issued a request for proposals on March 30, 2011 and TAMU was among the applicants. The contract was awarded following a year-long competitive nationwide process.
“The Texas A&M System is the prime contractor for a team of world-class academic, commercial and non-profit institutions. This highly integrated R&D team will utilize state-of-the-art processes for development and testing of new vaccines and therapies,” said Sharp in a written statement.
Vice Chancellor for Strategic Initiatives Brett Giroir noted that securing the project would mean “hundreds of millions of dollars in up front federal investment, and a 25-year potential commitment.”The center will be located on a site of nearly 150 acres owned by the city of Bryan. Upwards of 1,000 jobs are expected to be created by the addition of the center.